Diagnostics tops new cancer network agenda in UK
This article was originally published in Clinica
Executive Summary
Improved access to diagnostics and treatment technology is the main aim of the UK National Translational Cancer Research Network (NTRAC). Its role will be to co-ordinate the work of at least eight of the UK's most prominent scientific and clinical research institutions, with the aim of increasing the number of early clinical trials and by improving the efficiency of their assessment at national level.